The next breakthrough in weight loss medicine may not be a stronger drug. It may simply be a drug people are more likely to keep taking. Pfizer's experimental obesity treatment, berobenatide, could reduce Medicare can cover Eli Lilly's Zepbound for sleep apnea: Health Department agency Weight Loss Medications Pose New Challenges for Benefit Leaders Eli Lilly is still seeking UK approval on pen for weight loss drug Reuters The Most Valuable GameStop Promos In The Pokemon TCG GERD: Symptoms, causes, and treatment